Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells

This publication has 22 references indexed in Scilit:

• Antiestrogen Resistance: Mechanisms by Which Breast Cancer Cells Undermine the Effectiveness of Endocrine Therapy
  JNCI Journal of the National Cancer Institute, 1991
• A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer
  British Journal of Cancer, 1989
• Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells
  British Journal of Cancer, 1989
• Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and stability of the resistant phenotype
  British Journal of Cancer, 1989
• Biology and mode of action of pure antioestrogens
  Journal of Steroid Biochemistry, 1988
• Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapy
  European Journal of Cancer and Clinical Oncology, 1987
• Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines
  British Journal of Cancer, 1986
• Selection and Characterization of a Breast Cancer Cell Line Resistant to the Antiestrogen LY 117018
  Endocrinology, 1985
• The pharmacology and clinical uses of tamoxifen
  Pharmacology & Therapeutics, 1984
• A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
  JNCI Journal of the National Cancer Institute, 1973